Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein

Molecular Medicine

Volumn 4, Issue 6, 1998, Pages 384-391

  Bera, Tapan K ^a   Kennedy, Paul E ^b   Berger, Edward A ^b   Barbas III, Carlos F ^c   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOTOXIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; PSEUDOMONAS; VIRUS INHIBITION; VIRUS LOAD;

EID: 0031813707     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401745     Document Type: Article

References (27)

1. Barre-Sinoussi F, Chermann JC, Rey F. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871.
2. Popovic M, Sarngadharan MG, Read E, Gallo RC. (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497-500.
3. Perelson AS, Essunger P, Cao Y, et al. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387: 188-191.
4. Cavert W, Notermans DW, Staskus K, et al. (1997) Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276: 960-964.
5. Pastan I, Pai LH, Brinkmann U, FitzGerald DJ. (1995) Recombinant toxins: new therapeutic agents for cancer. Ann. N. Y. Acad. Sci. 758: 345-354.
6. Thrush GR, Lark LR, Clinchy BC, Vitetta, ES. (1996) Immunotoxins: an update. Annu. Rev. Immunol. 14: 49-71.
7. Pai LH, Wittes R, Setser A, Willingham MC, Pastan I. (1996) Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nature Med. 2: 350-353.
8. Burton DR, Barbas CF 3rd, Persson MA, Koenig S, Chanock RM, Lerner RA. (1991) A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. U.S.A. 88: 10134-10137.
9. Kessler JA 2nd, McKenna PM, Emini EA, et al. (1997) Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. AIDS Res. Hum. Retroviruses 13: 575-582.
10. Burton DR, Pyati J, Koduri R, et al. (1994) Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal-antibody. Science 266: 1024-1027.
11. Trkola A, Pomales AB, Yuan H, et al. (1995) Cross-clade neutralization of primary isolates of human-immunodeficiency-virus type-1 by human monoclonal-antibodies and tetrameric CD4-IgG. J. Virol. 69: 6609-6617.
12. Barbas CF 3rd, Hu D, Dunlop N, et al. (1994) In vitro evolution of a neutrilizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc. Natl. Acad. Sci. U.S.A. 91: 3809-3813.
13. Hwang J, FitzGerald DJ, Adhya S, Pastan I. (1987) Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48: 129-136.
14. Studier FW, Moffatt BA. (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189: 113-130.
15. Brinkmann U, Pastan I. (1995) Recombinant immunotoxins: from basic research to cancer therapy. Methods: A Companion to Methods Enzymol. 8: 143-185.
16. Buchner J, Pastan I, Brinkmann U. (1992) A method to increase the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205: 263-270.
17. Brinkmann U, Pai LH, FitzGerald DJ, Willingham M, Pastan I. (1991). B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. U.S.A. 88: 8616-8620.
18. Reiter Y, Brinkmann U, Lee B, Pastan I. (1996) Engineering antibody Fv fragments for cancer detection and therapy: disulfide stabilized Fv fragments. Nature Biotech. 14: 1239-1245.
19. Chaudhary VK, Mizukami T, Fuerst TR, et al. (1988) Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein. Nature 335: 369-372.
20. Webber KO, Reiter Y, Brinkmann U, Kreitman R, Pastan I. (1995) Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog. Mol. Immunol. 32:2 49-58.
21. Till MA, Ghetie V, Grerory T, et al. (1988) HIV-infected cells are killed by rCD4-ricin A chain. Science 242: 1166-1168.
22. Pincus SH, Cole RL, Hersh EM. (1991) In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. J. Immunol. 146: 4315-4324.
23. Pincus SH (1996) Therapeutic potential of anti-HIV immunotoxins. Antiviral Res. 33: 1-9.
24. Till MA, Zolla-Pazner S, Gorny MK, Patton JS, Uhr JW, Vitell ES. (1989) Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain. Proc. Natl. Acad. Sci. U.S.A. 86: 1987-1991.
25. Ashorn P, Moss B, Weinstein JN, et al. (1990) Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 87: 8889-8893.
26. Ramachandran RV, Katzenstein DA, Wood R, Batts DH, Merigan TC. (1994) Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons. J. Infect. Dis. 170: 1009-1013.
27. Davey RT Jr, Boenning CM, Herpin BR, et al. (1994) Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus. J. Infect. Dis. 170: 1180-1188.